| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.37 | 0.007 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |